Borgogni E et al. - Elocalcitol and MMI inhibited Th1 cytokine-mediated responses in thyrocytes and CD4+ T cells. In addition, elocalcitol promoted a shift toward a Th2 response. Elocalcitol could represent a novel pharmacological tool in the treatment of autoimmune thyroid diseases.